Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Proc Natl Acad Sci U S A
1999 Oct 12;9621:12079-84. doi: 10.1073/pnas.96.21.12079.
Show Gene links
Show Anatomy links
Selective expression of the large neutral amino acid transporter at the blood-brain barrier.
Boado RJ
,
Li JY
,
Nagaya M
,
Zhang C
,
Pardridge WM
.
???displayArticle.abstract???
Amino acid supply in brain is regulated by the activity of the large neutral amino acid transporter (LAT) at the braincapillary endothelial cell, which forms the blood-brain barrier (BBB) in vivo. Bovine BBB poly(A)(+) RNA was isolated from 2.0 kg of fresh bovine brain and size fractionated on a sucrose density gradient, and a size-fractionated bovine BBB cDNA library in the pSPORT vector was prepared. The full-length cDNA encoding the bovine BBB LAT was isolated from this library, and the predicted amino acid sequence was 89-92% identical to the LAT1 isoform. The bovine BBB LAT1 mRNA produced a 10-fold enhancement in tryptophan transport into frog oocytes coinjected with bovine BBB LAT1 mRNA and the mRNA for 4F2hc, which encodes the heavy chain of the heterodimer. Tryptophan transport into the mRNA-injected oocytes was sodium independent and was specifically inhibited by other large neutral amino acids, and the K(m) of tryptophan transport was 31.5 +/- 5.5 microM. Northern blotting with the bovine BBB LAT1 cDNA showed that the LAT1 mRNA is 100-fold higher in isolated bovine brain capillaries compared with C6 rat glioma cells or rat brain, and the LAT1 mRNA was not detected in rat liver, heart, lung, or kidney. These studies show that the LAT1 transcript is selectively expressed at the BBB compared with other tissues, and the abundance of the LAT1 mRNA at the BBB is manyfold higher than that of transcripts such as the 4F2hc antigen, actin, or the Glut1 glucose transporter.
Boado,
The brain-type glucose transporter mRNA is specifically expressed at the blood-brain barrier.
1990, Pubmed
Boado,
The brain-type glucose transporter mRNA is specifically expressed at the blood-brain barrier.
1990,
Pubmed
Boado,
Molecular cloning of the bovine blood-brain barrier glucose transporter cDNA and demonstration of phylogenetic conservation of the 5'-untranslated region.
1990,
Pubmed
Boado,
Evidence for translational control elements within the 5'-untranslated region of GLUT1 glucose transporter mRNA.
1996,
Pubmed
Boado,
A one-step procedure for isolation of poly(A)+ mRNA from isolated brain capillaries and endothelial cells in culture.
1991,
Pubmed
Boado,
Up-regulation of blood-brain barrier short-form leptin receptor gene products in rats fed a high fat diet.
1998,
Pubmed
Boado,
Measurement of blood-brain barrier GLUT1 glucose transporter and actin mRNA by a quantitative polymerase chain reaction assay.
1994,
Pubmed
Brakke,
Linear-log sucrose gradients for estimating sedimentation coefficients of plant viruses and nucleic acids.
1970,
Pubmed
Christensen,
Gene-product designations for amino acid transporters.
1994,
Pubmed
Freedman,
Sparing of the brain in neonatal undernutrition: amino acid transport and incorporation into brain and muscle.
1980,
Pubmed
Gillis,
The adenosine-uridine binding factor recognizes the AU-rich elements of cytokine, lymphokine, and oncogene mRNAs.
1991,
Pubmed
Hediger,
Expression cloning and cDNA sequencing of the Na+/glucose co-transporter.
,
Pubmed
,
Xenbase
Kanai,
Expression cloning and characterization of a transporter for large neutral amino acids activated by the heavy chain of 4F2 antigen (CD98).
1998,
Pubmed
,
Xenbase
Lund-Andersen,
Transport of glucose from blood to brain.
1979,
Pubmed
Malandro,
Molecular biology of mammalian amino acid transporters.
1996,
Pubmed
,
Xenbase
Miller,
Kinetic constants for blood-brain barrier amino acid transport in conscious rats.
1985,
Pubmed
Nakamura,
4F2 (CD98) heavy chain is associated covalently with an amino acid transporter and controls intracellular trafficking and membrane topology of 4F2 heterodimer.
1999,
Pubmed
,
Xenbase
Oldendorf,
Brain uptake of radiolabeled amino acids, amines, and hexoses after arterial injection.
1971,
Pubmed
Pardridge,
Brain-type glucose transporter (GLUT-1) is selectively localized to the blood-brain barrier. Studies with quantitative western blotting and in situ hybridization.
1990,
Pubmed
Pardridge,
Carotid artery injection technique: bounds for bolus mixing by plasma and by brain.
1985,
Pubmed
Pardridge,
Brain metabolism: a perspective from the blood-brain barrier.
1983,
Pubmed
Pardridge,
Blood-brain barrier carrier-mediated transport and brain metabolism of amino acids.
1998,
Pubmed
Pineda,
Identification of a membrane protein, LAT-2, that Co-expresses with 4F2 heavy chain, an L-type amino acid transport activity with broad specificity for small and large zwitterionic amino acids.
1999,
Pubmed
,
Xenbase
Prasad,
Human LAT1, a subunit of system L amino acid transporter: molecular cloning and transport function.
1999,
Pubmed
Sang,
TA1, a highly conserved oncofetal complementary DNA from rat hepatoma, encodes an integral membrane protein associated with liver development, carcinogenesis, and cell activation.
1995,
Pubmed
Sanger,
DNA sequencing with chain-terminating inhibitors.
1977,
Pubmed
Segawa,
Identification and functional characterization of a Na+-independent neutral amino acid transporter with broad substrate selectivity.
1999,
Pubmed
,
Xenbase
Shaw,
A conserved AU sequence from the 3' untranslated region of GM-CSF mRNA mediates selective mRNA degradation.
1986,
Pubmed
Wells,
The 4F2 antigen heavy chain induces uptake of neutral and dibasic amino acids in Xenopus oocytes.
1992,
Pubmed
,
Xenbase
